Comparison of the effect of Ropivacaine-Fentanyl and Ropivacaine-Sufentanil administration on spinal anesthesia
Phase 3
Completed
- Conditions
- .
- Registration Number
- IRCT20081013001328N2
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Age 18 years and above
Candidate for lower limb surgery under spinal anesthesia
ASA class I and II
informed consent to enter the study
Exclusion Criteria
Infection at the injection site
Coagulation disorders and the use of anticoagulants
Suffering from high intracranial pressure
Drug addiction
Patients with body mass index (BMI) above 30
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time to onset of the numbing. Timepoint: Every 30 seconds from the moment of injection to the first feeling of numbing at the level of the L4 vertebra. Method of measurement: Pinprick and Timer.;Duration of reaching the maximum level of numbing. Timepoint: Every 30 seconds from the moment of injection to numbing of the T12 vertebra surface. Method of measurement: Pinprick and Timer.;Duration of return of numbing. Timepoint: From the time of drug injection until the return of sensation at S1 level. Method of measurement: Pinprick and Timer.
- Secondary Outcome Measures
Name Time Method Blood Pressure. Timepoint: before the injection, 3, 5, and 10 minutes after the spinal and then every 15 minutes until the end of recovery. Method of measurement: Sphymomanmeter.;Heart Rate. Timepoint: before the injection, 3, 5, and 10 minutes after the spinal and then every 15 minutes until the end of recovery. Method of measurement: ECG monitoring.;Oxygen Saturation. Timepoint: From the moment of entering the operating room until the end of recovery. Method of measurement: Pulse Oximeter.